OPS-Code 8-530.b1:
Nuclear medicine therapy: Therapy with unsealed radionuclides: Intracavity radiotherapy with unsealed radionuclides: Intracavity radionuclide therapy with radioactive antibodies
A radioactive drug that was bound to an antibody was introduced into a cavity in your body.
The body has a number of cavities that contain various organs. For example, the chest cavity contains the lungs and heart, while the abdominal cavity contains the abdominal organs.
Antibodies are defensive substances that occur in the body. However, antibodies can also be synthetically manufactured to treat certain illnesses. Antibodies detect proteins on the surface of cells and bind to them. Each specific antibody only ever binds to its matching proteins. The cells of the body have typical proteins on their surfaces that differ depending on the type, role and origin of the cell.
The radioactive drug accumulates in the site in the body where the antibody binds to the relevant protein. The radiation emitted by the radioactive drug takes effect at this site. The intention is for the radiation to damage pathologically altered cells in the body.
Additional indicator
If necessary, additional letters are appended to OPS codes to indicate which side of the body is affected.
- L: Left
- R: Right
- B: Both sides
Note
Your doctor will assist you with any health-related questions and explain the OPS code to you in a direct consultation if necessary.
Source
The explanation of the OPS code was provided by the non-profit organization “Was hab’ ich?” gemeinnützige GmbH on behalf of the Federal Ministry of Health (BMG).